Bethesda, MD, January 30, 2023 – Lumanity today announced that it has enhanced its medical affairs offering with the integration of medical affairs consulting capabilities under the Lumanity brand.
Lumanity has built a leadership position in medical affairs with best-in-class consulting, communications, clinical and regulatory, health outcomes and real world evidence, and patient advocacy and engagement services. This comprehensive offering was further enhanced with the integration of additional consulting capabilities from Zipher Medical Affairs, acquired in 2022 and now rebranded to Lumanity. These medical affairs consulting capabilities, enable Lumanity to work with its clients to build and optimize medical affairs organizations; develop and implement medical strategic plans; design, evaluate, and execute data generation programs; and accelerate launch readiness. The purpose-built and uniquely integrated nature of Lumanity’s medical affairs practice allows the company to support clients in their efforts to: attain a balanced multi-stakeholder perspective, influence regulatory strategy and path, and effectively engage customers through a deeper understanding of data, insights, and tools.
Peg Crowley-Nowick, former President of Zipher, now President of Medical Affairs Consulting at Lumanity said, “Change in the biopharma industry is a constant, and no one understands that truth better than the medical affairs functions within these organizations. The role of medical affairs has expanded far beyond scientific communication and education. Today, medical affairs consultants are a key strategic partner within the drug development process, providing critical insights into market access, real world evidence, and patient-centric approaches to care. It truly is a thrilling time to be in this industry, and I’m incredibly excited with the breadth and depth of offerings we can now provide to our clients.”
Lumanity’s medical affairs offering is further enhanced by its broad expertise in real world evidence, patient-centered outcomes, patient engagement, and creative and digital innovation. Jon Williams, CEO of Lumanity said, “Bringing our deep knowledge and capabilities in medical affairs together with the breadth of offerings across the organization provides unique and impactful solutions for our clients. Our focus on developing innovative solutions to improve the experience for patients worldwide has been strengthened by the addition of Zipher and the foundation it has provided to build new capabilities in the medical affairs space.”
For more information on Lumanity’s medical affairs capabilities, visit its webpage.